%0 Generic
%A Shu, C. A.
%A Goto, K.
%A Ohe, Y.
%A Besse, B.
%A Park, K.
%A Wang, Y.
%A Griesinger, F.
%A Yang, J. C-H.
%A Felip, E.
%A Sanborn, R. E.
%A Caro, R. Bernabe
%A Bauml, J. M.
%A Chen, J.
%A Fennema, E.
%A Mahoney, J.
%A Trani, L.
%A Knoblauch, R. E.
%A Thayu, M.
%A Cho, B. C.
%T Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/27229
%~